S-adenosyl-homocysteine-hydrolase (AHCY) plays an important role in the methionine cycle regulating cellular methylation levels. AHCY has been reported to influence proliferation and differentiation processes in different cell types, e.g. in cancer cells and mouse embryonic stem cells. In the development of adipose tissue, both the proliferation and differentiation of adipocyte progenitor cells (APCs) are important processes, which in the context of obesity are often dysregulated. To assess whether AHCY might also be involved in cell proliferation and differentiation of APCs, we investigated the effect of reduced AHCY activity on human and mouse APCs . We show that the inhibition of AHCY using adenosine dialdehyde (AdOx) and the knockdown of AHCY using gene-specific siRNAs reduced APC proliferation and number. Inhibition of AHCY further reduced APC differentiation into mature adipocytes and the expression of adipogenic differentiation markers. Global DNA methylation profiling in human APCs revealed that inhibition of AHCY is associated with alterations in CpG methylation levels of genes involved in fat cell differentiation and pathways related to cellular growth. Our findings suggest that AHCY is necessary for the maintenance of APC proliferation and differentiation and inhibition of AHCY alters DNA methylation processes leading to a dysregulation of the expression of genes involved in the regulation of these processes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732623PMC
http://dx.doi.org/10.1080/21623945.2023.2290218DOI Listing

Publication Analysis

Top Keywords

inhibition ahcy
20
proliferation differentiation
20
ahcy
10
differentiation
8
adipocyte progenitor
8
progenitor cells
8
methylation levels
8
reduced apc
8
apc proliferation
8
dna methylation
8

Similar Publications

Glioblastoma (GBM) is a highly aggressive primary malignant adult brain tumor that inevitably recurs with a fatal prognosis. This is due in part to metabolic reprogramming that allows tumors to evade treatment. We therefore must uncover the pathways mediating these adaptations to develop novel and effective treatments.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis is a widespread chronic skin condition, and the role of S-adenosine homocysteine hydrolase (AHCY) in its development and its effects on DNA methylation had not been thoroughly examined.
  • This study explored how AHCY expression in psoriatic lesions relates to disease severity and its effects on keratinocyte behavior and DNA methylation through knockdown experiments.
  • The results show that AHCY is elevated in psoriasis, contributes to disease severity, and alters DNA methylation patterns, suggesting that targeting AHCY could be a potential therapeutic approach for treating psoriasis.
View Article and Find Full Text PDF
Article Synopsis
  • DZNep is a compound that inhibits the enzyme AHCY, reducing the conversion of SAH to L-homocysteine, which lowers methylation potential in cells.
  • Recent research has utilized the PISA assay to explore how DZNep treatment affects the thermal stability of proteins, finding that it impacted 135 proteins, many of which were previously known to be methylated.
  • The study identifies that a significant number of thermally altered proteins did not show changes at the transcript or protein abundance levels, highlighting direct effects on protein stability and including specific proteins like CDK6 and various methyltransferases.
View Article and Find Full Text PDF

Inhibition of AHCY impedes proliferation and differentiation of mouse and human adipocyte progenitor cells.

Adipocyte

December 2024

Center for Pediatric Research Leipzig (CPL), Hospital for Children & Adolescents, University of Leipzig, Leipzig, Germany.

S-adenosyl-homocysteine-hydrolase (AHCY) plays an important role in the methionine cycle regulating cellular methylation levels. AHCY has been reported to influence proliferation and differentiation processes in different cell types, e.g.

View Article and Find Full Text PDF

Adenosylhomocysteinase (AHCY), a key enzyme in the methionine cycle, is essential for the development of embryos and the maintenance of mouse embryonic stem cells (mESCs). However, the precise underlying mechanism of Ahcy in regulating pluripotency remains unclear. As the only enzyme that can hydrolyze S-adenosylhomocysteine in mammals, AHCY plays a critical role in the metabolic homeostasis, epigenetic remodeling, and transcriptional regulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!